Terms: = Colorectal cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
66 results:
1. PROGNOSTIC SIGNIFICANCE OF microRNA-100, -125b, AND -200b IN PATIENTS WITH colorectal cancer.
Maliborska S; Holotiuk V; Partykevych Y; Rossylna O
Exp Oncol; 2024 Feb; 45(4):443-450. PubMed ID: 38328846
[TBL] [Abstract] [Full Text] [Related]
2. A spectroscopic liquid biopsy for the earlier detection of multiple cancer types.
Cameron JM; Sala A; Antoniou G; Brennan PM; Butler HJ; Conn JJA; Connal S; Curran T; Hegarty MG; McHardy RG; Orringer D; Palmer DS; Smith BR; Baker MJ
Br J Cancer; 2023 Nov; 129(10):1658-1666. PubMed ID: 37717120
[TBL] [Abstract] [Full Text] [Related]
3. Narrative Review of Probiotic Use on the Recovery of Postoperative Patients with Esophageal cancer.
Co EL; Hameed M; Sebastian SA; Garg T; Sudan S; Bheemisetty N; Mohan B
Curr Nutr Rep; 2023 Dec; 12(4):635-642. PubMed ID: 37605086
[TBL] [Abstract] [Full Text] [Related]
4. The Next Best Thing: Three Key Conversations to Convey prognosis Over the Course of an Incurable cancer.
Gage L; Teply M
Clin Colorectal Cancer; 2023 Dec; 22(4):354-360. PubMed ID: 37507247
[TBL] [Abstract] [Full Text] [Related]
5. [Prognostic histological markers in colorectal cancer].
Quaas A
Pathologie (Heidelb); 2023 Sep; 44(5):287-293. PubMed ID: 37368053
[TBL] [Abstract] [Full Text] [Related]
6. The role of Fusobacteria in oral cancer and immune evasion.
Harrandah AM
Curr Opin Oncol; 2023 Mar; 35(2):125-131. PubMed ID: 36633319
[TBL] [Abstract] [Full Text] [Related]
7. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract] [Full Text] [Related]
8. Plant-Based Diets and cancer prognosis: a Review of Recent Research.
Hardt L; Mahamat-Saleh Y; Aune D; Schlesinger S
Curr Nutr Rep; 2022 Dec; 11(4):695-716. PubMed ID: 36138327
[TBL] [Abstract] [Full Text] [Related]
9. Metabolic syndrome, obesity and cancer risk.
Belladelli F; Montorsi F; Martini A
Curr Opin Urol; 2022 Nov; 32(6):594-597. PubMed ID: 36081396
[TBL] [Abstract] [Full Text] [Related]
10. Interventions to Reduce Sedentary Behavior in cancer Patients and Survivors: a Systematic Review.
Belcher BR; Kang DW; Yunker AG; Dieli-Conwright CM
Curr Oncol Rep; 2022 Nov; 24(11):1593-1605. PubMed ID: 35829982
[TBL] [Abstract] [Full Text] [Related]
11. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic colorectal cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA
Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913
[TBL] [Abstract] [Full Text] [Related]
12. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer.
Liu Z; Liu Z; Zhou X; Lu Y; Yao Y; Wang W; Lu S; Wang B; Li F; Fu W
Hum Genomics; 2022 Feb; 16(1):5. PubMed ID: 35109912
[TBL] [Abstract] [Full Text] [Related]
13. Deficient Mismatch Repair and Lymphocytic Response to Tumor as Prognostic Markers in Stage II Colon cancer Patients.
Sari M; Atag E; Demir T; Simsek ET; Coban E; Cikrikcioglu M
J Coll Physicians Surg Pak; 2022 Feb; 32(2):186-192. PubMed ID: 35108789
[TBL] [Abstract] [Full Text] [Related]
14. Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated colorectal cancer: A Systematic Review and Meta-analysis.
Lu C; Schardey J; Zhang T; Crispin A; Wirth U; Karcz KW; Bazhin AV; Andrassy J; Werner J; Kühn F
Ann Surg; 2022 Nov; 276(5):e319-e330. PubMed ID: 34913897
[TBL] [Abstract] [Full Text] [Related]
15. Does Prognostic Nutritional Index Predict Survival in Operated Papilla Vateri Tumors? A Single-centre Experience.
Bardakci M; Hafizoglu E; Kos FT; Uncu D
J Coll Physicians Surg Pak; 2021 Dec; 31(12):1428-1432. PubMed ID: 34794282
[TBL] [Abstract] [Full Text] [Related]
16. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
Wu X; Lu Y; Qin X
J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
[TBL] [Abstract] [Full Text] [Related]
17. Characteristics of Patients Undergoing Surgical Treatment for Spinal Metastases From colorectal cancer: A Comparison With Non-Small Cell Lung cancer.
Park SJ; Park JS; Nam Y; Lee CS
Clin Spine Surg; 2022 Feb; 35(1):E187-E193. PubMed ID: 34379609
[TBL] [Abstract] [Full Text] [Related]
18. Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy.
Lin YM; Taiji R; Calandri M; Odisio BC
Curr Oncol Rep; 2021 Apr; 23(6):67. PubMed ID: 33855606
[TBL] [Abstract] [Full Text] [Related]
19. Preoperative Hepatic and Regional Arterial Chemotherapy in Patients Who Underwent Curative colorectal cancer Resection: A Prospective, Multi-center, Randomized Controlled Trial.
Zhu D; Xia J; Gu Y; Lin J; Ding K; Zhou B; Liang F; Liu T; Qin C; Wei Y; Ren L; Zhong Y; Wang J; Yan Z; Cheng J; Chen J; Chang W; Zhan S; Ding Y; Huo H; Liu F; Sun J; Qin X; Xu J
Ann Surg; 2021 Jun; 273(6):1066-1075. PubMed ID: 33214446
[TBL] [Abstract] [Full Text] [Related]
20. Ileo-colonic lymphoma: presentation, diagnosis, and management.
Panneerselvam K; Goyal S; Shirwaikar Thomas A
Curr Opin Gastroenterol; 2021 Jan; 37(1):52-58. PubMed ID: 33105251
[TBL] [Abstract] [Full Text] [Related]
[Next]
